PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Albain, Kathy S.
TI  - Treatment on the Edges: Discordance between Stage and Biology
DP  - 2013 Mar 01
TA  - MD Conference Express
PG  - 4--5
VI  - 12
IP  - 20
4099  - http://mdc.sagepub.com/content/12/20/4.short
4100  - http://mdc.sagepub.com/content/12/20/4.full
AB  - One of the more difficult issues that clinicians face when helping patients make adjuvant therapy decisions is what to do when discordance exists between two important predictors of relapse risk: tumor stage and tumor biology [Albain KS. SABCS 2012 (abstr CS1–1)]. Patients with higher-stage tumors (ie, large tumors, multiple positive lymph nodes) of favorable biology (eg, luminal A tumors) and those with the opposite situation (ie, small tumors with aggressive biology) can render adjuvant therapy choices difficult.